OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis
Emma L. Ledger, Daniel J. Smith, Jing Jie Teh, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e536-e547
Open Access | Times Cited: 6
Emma L. Ledger, Daniel J. Smith, Jing Jie Teh, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e536-e547
Open Access | Times Cited: 6
Showing 6 citing articles:
Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
Yahya H. Dallal Bashi, Rachel Mairs, Rand Murtadha, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 111-111
Open Access
Yahya H. Dallal Bashi, Rachel Mairs, Rand Murtadha, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 111-111
Open Access
Phage Therapy for Respiratory Infections: Opportunities and Challenges
Arya Khosravi, Qingquan Chen, Arne Echterhof, et al.
Lung (2024) Vol. 202, Iss. 3, pp. 223-232
Closed Access | Times Cited: 4
Arya Khosravi, Qingquan Chen, Arne Echterhof, et al.
Lung (2024) Vol. 202, Iss. 3, pp. 223-232
Closed Access | Times Cited: 4
Antibiofilm activity of Prevotella species from the cystic fibrosis lung microbiota against Pseudomonas aeruginosa
Lucia Grassi, Kyle L. Asfahl, Sara Van den Bossche, et al.
Biofilm (2024) Vol. 7, pp. 100206-100206
Open Access
Lucia Grassi, Kyle L. Asfahl, Sara Van den Bossche, et al.
Biofilm (2024) Vol. 7, pp. 100206-100206
Open Access
Therapeutic Interventions for Pseudomonas Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials
Mohammed Alqasmi
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6530-6530
Open Access
Mohammed Alqasmi
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6530-6530
Open Access
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population
Lindsay Somerville, Borish Larry, Noth Imre, et al.
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access
Lindsay Somerville, Borish Larry, Noth Imre, et al.
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access
Outcomes of Modulator Therapy Discontinued After Short‐Term Use in Adult Cystic Fibrosis
Oğuz Karcıoğlu, Aytekin İdikut, Ebru Öztürk, et al.
Pediatric Pulmonology (2024)
Open Access
Oğuz Karcıoğlu, Aytekin İdikut, Ebru Öztürk, et al.
Pediatric Pulmonology (2024)
Open Access
